ABSTRACT-Effects of heparin on the inhibitory activities of human urinary trypsin inhibitor (ulinastatin) on trypsin, chymotrypsin and leukocyte elastase were studied. Heparin per se neither influenced the en zymatic activities nor changed the mode of inhibition of ulinastatin on the enzymes. In the presence of heparin, inhibitory effects of ulinastatin on trypsin were enhanced, whereas its effects on chymotrypsin and elastase were attenuated. These results suggest that the two functional domains in ulinastatin are differently affected by heparin.
Ulinastatin (UT) and aprotinin, derived respectively from human urine and bovine lung, are used as remedies for acute pancreatitis. They display inhibitory effects on trypsin, chymotrypsin and leukocyte elastase (1, 2) . Although both these inhibitors are highly homologous in their amino acid sequences (3), their physicochemical properties are strikingly different. Aprotinin is a basic polypeptide with a molecular weight of about 6.5 kDa and shows an isoelectric point close to pH 10.5 (2), whereas UT, besides displaying an isoelectric point of 2.6 (4) , is an acidic mucoprotein with a molecular weight of 40 50 kDa in SDS-polyacrylamide gel electrophoresis (5) . UT has two functional domains: domain 1 (N-termi nal domain) inhibits chymotrypsin and leukocyte elastase activities, and domain 2 (C-terminal domain) suppresses trypsin activity (3). Previously, we have found that hepa rin enhances the inhibitory effect of aprotinin on the es terolytic activity of trypsin without altering the effect on the esterolytic activity of chymotrypsin (6) . This report showed that heparin differently influenced the UT activ ities on trypsin, chymotrypsin and leukocyte elastase. (containing 50 pl of 0.5 M Tris-HC1 buffer (pH 8), 50 p1 of 0.1 M CaC12, 100 pl of distilled water, 100 pl of UT so lution and 100 p1 of polysaccharide solution) was incubat ed with 50 p1 of the enzyme preparation at 371C for 5 min. Thereafter, 50 pl of substrate solution was added to the in cubation mixture, which was then allowed to incubate fur ther with trypsin, chymotrypsin and elastase at 371C for 30, 5 and 60 min, respectively. The enzymatically released 7-amino-4-methyl-coumarin (AMC) linearly increased during these reaction intervals. In the kinetic study, the reaction intervals used for trypsin, chymotrypsin and elastase were 15, 5 and 15 min, respectively. As the sub strates for trypsin, chymotrypsin and elastase, t-butyl
(Suc (OMe)-Ala-Ala-Pro-Val-MCA) were used, respectively. These synthetic substrates were products of Peptide Institute, Inc., Osaka. The reaction was stopped by the addition of 500 p1 of 20% acetic acid. Fluorescence intensities of the enzymatically released AMC in the reactions with trypsin, chymotrypsin and elastase were measured using excitation/emission wavelengths of 380/440 nm, 380/460 nm and 370/460 nm, respectively. As the polysaccharide, mucopolysaccha rides such as heparin (sodium salt from porcine intestinal mucosa, 150 USP units per mg, Sigma Chemical Co.), heparan sulfate (sodium salt from bovine kidney, Seikagaku Kogyo Co., Tokyo), chondroitin sulfate B (sodium salt from porcine skin, Seikagaku Kogyo Co.), chondroitin sulfate C (sodium salt from shark cartilage, Seikagaku Kogyo Co.) and hyaluronic acid (sodium salt from porcine skin, Seikagaku Kogyo Co.) were used. So dium dextran sulfate 5000 (Wako Pure Chemical Indus tries, Osaka) was also used as a sulfated polysaccharide. Fig. 1 . Effects of polysaccharides on the inhibitory activities of ulinastatin (UT) on trypsin (a), chymotrypsin (b) and leuko cyte elastase (c). Trypsin (6.25 ng/ml), chymotrypsin (100 ng/ml) and leukocyte elastase (0.4 pg/ml) were incubated with various quantities of polysaccharides without and with UT of 24 ng/ml, 80 ng/ml and 2 ,pg/ml in (a), (b) and (c), respectively. Substrates for (a), (b) and (c) were Boc-Gln-Ala-Arg-MCA (10-5 M), Suc-Ala-Ala-Pro-Phe-MCA (10-5 M) and Suc (OMe)-Ala Ala-Pro-Val-MCA (2 x 10-5 M), respectively. The enzymatic activity without UT was taken as 100%, and the inhibition % shown on the ordinate was calculated from the enzymatic activity with UT. Each column shows the mean value ± S.E.M. for 4 experiments. Significant differences from the control value (polysaccharide concentration, 0 mg/ml) (represented by the sym bol*) or from the value of corresponding column (represented by the symbol) were determined by Student's t-test: P < 0.05 (*, ), P<0.01 (**, 0), P<0.001 (***, "). H, HR, CDB, CDC, DS and HLA represent heparin, heparan sulfate, chondroitin sulfate B, chondroitin sulfate C, dextran sulfate and hyaluronic acid, respectively.
Among the polysaccharides, heparin enhanced the inhibitory effect of UT on trypsin (Fig. la) . However, the inhibitory effects of UT on chymotrypsin and elastase were attenuated in the presence of heparin (Fig. 1, b and  c) . Attenuation effects on UT activities were also observed with sulfated polysaccharides such as heparan sulfate, chondroitin sulfate B, chondroitin sulfate C and dextran sulfate, accordingly (Fig. 1, b and c) . However, hyalu ronic acid, which lacks the sulfate groups, did not affect the UT activity. These results indicate that the functional domains of UT, in which domain 1 (N-terminal domain) and 2 (C-terminal domain) inhibit chymotrypsin/leuko cyte elastase and trypsin activities (3), respectively, are differently affected by heparin. With regards to the attenu ation effects on the UT activity, chondroitin sulfate C was less potent than chondroitin sulfate B (compare CDC with CDB in Fig. 1, b and c) . Thus, not only the sulfate groups but differences in uronic acid and the position of sulfate groups also influenced the attenuation effect.
As for the mode of inhibition of UT on trypsin, chymotrypsin and leukocyte elastase, inhibitions on tryp sin and chymotrypsin were found to be noncompetitive, whereas that on elastase was uncompetitive (data not shown). This implicates that UT binds to trypsin (or chymotrypsin) and the trypsin • substrate (or chymotryp sin -substrate) complex, whereas UT per se does not bind to elastase, and instead it binds to the elastase • substrate complex. The inhibition mode of UT was not affected by heparin. From kinetic parameters of Lineweaver-Burk plots and Hofstee plots of the data (Table 1) , heparin alone did not have any effects on the activities of trypsin, chymotrypsin and elastase (compare Km value with and without heparin in Table 1 ). Even in the presence of UT, heparin did not have any effects on the respective appar ent Km value of trypsin and chymotrypsin ( Table 1) . The inhibitor constant (K;) values of UT for trypsin, chymotrypsin and elastase obtained in the absence of heparin were similar to those reported by Selloum et al. (7) . In the presence of heparin, the K, value of UT for tryp sin was decreased, whereas those for chymotrypsin and elastase were increased in the presence of heparin (Table  1) . Thus, heparin enhanced the complex formation of trypsin • UT and trypsin -substrate -UT, whereas it de creased the formation of complexes of chymotrypsin • UT and chymotrypsin -substrate • UT and that of elasatse substrate • UT. The similar mechanism was observed regarding the enhancing effect of heparin on the inhibi tory activity of aprotinin on trypsin (8) .
Under the present experimental conditions (incubation of enzyme with UT and polysaccharide before addition of substrate and short reaction time), the quantity of hepa rin required for the enhancement or attenuation effect of UT activities was more than 100-fold higher than that of UT (see legend of Fig. 1 ). This might be attributed to the properties of UT and heparin: Both substances have an anionic character. UT is an acidic mucoprotein (3), and the carbohydrate content of UT, which is partially respon sible for the anionic character of UT (7), is 35% (9) to 50% (10) of its molecular weight. Heparin is also an an ionic polysaccharide due to its sulfate and carboxylic groups. However, our present results imply that the presence of heparin and sulfated mucopolysaccharides (in connective tissue and vascular endothelium) may have a modulatory effect on the protease inhibitory activity of UT systemically infused into the body for the treatment of acute pancreatitis and shock, in which the release of pancreatic enzymes can induce pancreatic damage and accumulation of plasma trypsin (11, 12) . In addition, our results indicate that heparin may serve as a biochemical tool to modify or analyze the domain of UT which in fluences its biological functions, since the two functional domains of UT are differently affected by heparin. 
